(Press-News.org) Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain why ovarian cancer patients respond poorly to chemotherapy or relapse after treatment.
Published in Clinical Cancer Research, the study investigated chemotherapy-resistant cancer cells called quiescent cells. As chemotherapy primarily targets rapidly dividing cells, quiescent cells are resistant because they divide slowly. The researchers found that quiescent cells secrete a protein called follistatin that prompts neighbors to become resistant to chemotherapy too. By targeting this protein, they improved response to chemotherapy and boosted survival in a mouse model of aggressive ovarian cancer, paving the way for future human clinical trials.
“I think about quiescent cancer cells like the yellow center of a daisy and neighboring cells as the surrounding white petals,” said Ronald Buckanovich, M.D., Ph.D., professor of medicine at Pitt and co-director of the Women's Cancer Research Center — a collaboration between UPMC Hillman Cancer Center and Magee-Womens Research Institute. “In response to chemotherapy, quiescent cells secrete follistatin that acts like a signal to protect the whole flower. When chemotherapy stops, follistatin levels drop and cells start proliferating again, almost like a barometer that says, ‘Conditions are good to grow.’ This might explain why ovarian cancers often come back so quickly.”
Ovarian cancer is the deadliest form of gynecologic cancer in the U.S. More than 70% of patients who are treated for this disease will have the cancer return, and it is rarely curable in this form. According to Buckanovich, there is an urgent need for therapies to combat resistant cancer cells and reduce recurrence rates.
In the new study, Buckanovich and his team found that quiescent cells ramp up production of follistatin in response to chemotherapy drugs in both lab-grown human cells and mice.
Next, they showed that quiescent cells halt the growth of actively dividing cancer cells, making them resistant to chemotherapy drugs. When they blocked follistatin with an antibody, this effect was lost, demonstrating that follistatin drives chemotherapy resistance.
“We thought that quiescent cells would produce factors to make themselves resistant to chemotherapy, but the fact they also protect their neighbors and amplify chemoresistance was surprising,” said Buckanovich. “If some of these neighbors learn to be quiescent themselves, which in turn protect their own neighbors, more and more resistant cells will persist and lead to cancer recurrence.”
To further confirm the role of follistatin in driving chemoresistance, the team genetically deleted the gene encoding follistatin in tumor cells that initiate an aggressive and incurable form of ovarian cancer in mice. The results were dramatic: After chemotherapy, 30% of mice with tumors lacking follistatin were cured, while all mice with normal tumors died.
Next, the team analyzed Cancer Genome Atlas data from hundreds of ovarian cancer patients. They showed that higher levels follistatin levels were associated with worse survival rates, indicating that follistatin is also relevant in people.
Finally, they compared samples from ovarian cancer patients before and after chemotherapy. Follistatin levels doubled or tripled in just 24 hours after treatment.
“To me, the most exciting thing about this study was the fact that we saw this incredible response to chemotherapy in patients within 24 hours,” said Buckanovich. “These data reinforce our findings in mice and suggest that follistatin is a new target to improve ovarian cancer response to chemotherapy.”
Buckanovich is now working with Pitt’s Center for Antibody Therapeutics to develop antibodies for follistatin in humans with the eventual goal of moving this approach into clinical trials.
“If we’re able to reverse chemoresistance and fewer patients relapse, we might be able to increase cure rates,” he said. “Even if this approach works for 20% of patients, that would be huge because approximately 14,000 patients each year are dying from ovarian cancer.”
According to Buckanovich, other recent research has suggested that follistatin also drives immunotherapy resistance in ovarian cancer, suggesting that an antibody targeting this protein could potentially be used to augment both chemotherapy and immunotherapy.
The team also plans to investigate how follistatin causes chemotherapy resistance in cancer cells. Blocking these signals by developing new drugs or repurposing existing drugs could be another promising avenue to improve treatments for ovarian cancer in the future.
Other authors who contributed to this study are listed in the in Clinical Cancer Research study.
This research was supported by the Ovarian Cancer Research Alliance (599997), the Department of Defense (#W81XWH-15-1-0083) and the National Institutes of Health (1R01CA203810).
##
END
Chemotherapy-resistant ovarian cancer cells protect their neighbors
2023-03-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
When ‘good genes’ go bad: how sexual conflict can cause population collapse
2023-03-03
Males of a species evolving traits for sexual conflict can cause problems for females, and, ultimately, the whole population.
A new model by Imperial College London and University of Lausanne researchers, published in Proceedings of the National Academy of Sciences, shows how so-called ‘good genes’ can sometimes cause a population to collapse.
Males of any species may compete for females, either by fighting other males for access or impressing females to win their approval. In both cases, ...
UC Davis study uncovers age-related brain differences in autistic individuals
2023-03-03
A new study led by UC Davis MIND Institute researchers confirms that brain development in people with autism differs from those with typical neurodevelopment. According to the study published in PNAS, these differences are linked to genes involved in inflammation, immunity response and neural transmissions. They begin in childhood and evolve across the lifespan.
About one in 44 children in the U.S. has autism. Autistic individuals may behave, communicate and learn in ways that are different from neurotypical people. As they age, they often have challenges with social communication ...
An interdisciplinary solution for enhanced high-resolution imaging in electron and optical microscopy
2023-03-03
Although electron microscopy can already reveal details as small as one nanometer, ongoing research seeks to break through barriers limiting image quality and reducing the optical dose on the samples. Aberration is a common problem in electron microscopy that can reduce the resolution and quality of the images produced. Additional complex phase and amplitude controls are needed in these microscopes. An international team of researchers led by Akhil Kallepalli (Kallepalli Lab) working within the Optics Group at the University of Glasgow set out to address the problem. Working from an optics perspective, they developed and tested a new ghost ...
Tree rings and strontium point researchers to the provenance of 400-year-old timber
2023-03-03
Tree-ring analysis – so-called dendrochronological analysis – has been part of archaeology for many years and has made it possible for archaeologists to date old wooden objects with great precision. And in many cases, they have also been able to determine the provenance of the wood.
But it has proven difficult for researchers to determine timber’s place of origin when the historic timber was imported into Denmark from further afield to serve as building material.
In a new study in the journal PLOS ONE, Associate Professor Aoife Daly and Dr Alicia Van Ham-Meert from the University of Copenhagen show that combining analyses of ...
Chinese scientists discovered roles of hypothalamic amino acid sensing in antidepressant effects
2023-03-03
Depression is a leading cause of disability around the world and contributes greatly to the global burden of disease. Nutrition is essential for the maintenance of normal emotional states. Nutritional therapy is rising up in many disease treatments, but little is known in the depression field. Unbalanced nutrition is implicated in the etiology of depression, potentially hindering treatment. For example, many essential amino acids (EAAs) in serum are changed in patients with depression, such as tryptophan, threonine, leucine, isoleucine, and valine. However, whether EAA contributes to depression ...
Health policy experts call for confronting anti-vaccine activism with life-saving counter narratives
2023-03-03
Public and private sector health officials and public policymakers should team up immediately with community leaders to more effectively disseminate accurate narratives regarding the life-saving benefits of vaccines to counter widespread, harmful misinformation from anti-vaccine activists.
Such is the message of a UC Riverside-led viewpoint piece published Thursday, March 2, in the leading international medical journal, The Lancet.
“We need to consistently amplify the best science and find the best ways of communicating so that people are hearing it through multiple channels instead of through one or two sources,” ...
Inspirational women from UK Synchrotron launch major recruitment campaign to promote STEM careers at AAAS international science conference
2023-03-03
Today, at the prestigious AAAS science conference in Washington DC, Diamond Light Source, the UK’s synchrotron science facility, will unveil plans for its biggest recruitment campaign since its inception 20 years ago. Dozens of new roles will be available in the coming year and some examples of the variety of STEM careers will be showcased and celebrated by an all-women line up from the Diamond team. This recruitment drive aims to ensure the facility has the knowledge and expertise required to help plan and deliver world leading science for the next decade and beyond
In the lead up to ...
Imaging the adolescent heart
2023-03-03
Magnetic resonance imaging (MRI) has allowed scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) to produce an accurate picture of the healthy heart in adolescence. Using this advanced technology, the research team was able to determine reference values for anatomical and functional parameters in the heart during adolescence. This information, pubished in eClinicalMedicine, has direct implications for clinical practice.
“Magnetic resonance imaging has become a very important method for studying the heart because it avoids exposing patients to radiation ...
Archaeological study of 24 ancient Mexican cities reveals that collective forms of governance, infrastructural investments, and collaboration all help societies last longer
2023-03-03
Some cities only last a century or two, while others last for a thousand years or more. Often, there aren’t clear records left behind to explain why. Instead, archaeologists piece together clues from the cities’ remains to search for patterns that help account for why certain places retained their importance longer than others. In a new study published in the journal Frontiers in Ecology and Evolution, researchers examined 24 ancient cities in what’s now Mexico and found that the cities that lasted the longest showed indications of collective forms of governance, infrastructural investments, and cooperation between households.
“For years, my colleagues and I have ...
50 leading national organizations unite to curb infodemic of health and science misinformation and disinformation
2023-03-03
The Coalition for Trust in Health & Science today announced its formation and public launch during the 2023 American Association for the Advancement of Science (AAAS) Annual Meeting in Washington, D.C. The alliance was formed to unite leading organizations from across the entire health ecosystem to advance trust and factual science-based decision-making. The partnership aims to achieve a measurable increase in the public’s willingness – and ability – to access evidence-based information necessary to make the best personally appropriate health decisions for themselves, their ...